MBX Biosciences, Inc. — Form D

MBX Biosciences, Inc. of CARMEL, IN, a company, filed a Form D exempt-offering notice with the SEC on 2019-05-10. The offering totals $50.0M, of which $23.0M was reported sold. Industry: Pharmaceuticals.

Offering

Filed: 2019-05-10
Form: D
Accession: 0001776111-19-000001
Industry: Pharmaceuticals
Exemptions: 06b
Total offering: $50.0M
Amount sold: $23.0M
Remaining: $27.0M
Investors: 9
Date of first sale: 2019-04-25
Security types: debt
Revenue range: Decline to Disclose
SEC file number: 021-339344

Issuer

Name: MBX Biosciences, Inc.
CIK: 0001776111
Entity type: Corporation
Jurisdiction: DELAWARE
Incorporated: 2019
Address: 11711 N. Meridian Street, Suite 300, CARMEL, IN, 46032
Phone: 317-659-0200

Officers, directors & promoters (13)

Name	Role	Location
James M Cornelius	Director	Carmel, IN
Patrick M Heron	Director	Carmel, IN
Edward M Mathers	Director	Carmel, IN
Richard Kent DiMarchi	Director	Carmel, IN
Richard Kent DiMarchi	Executive Officer	Carmel, IN
Tiba M Aynechi	Director	Carmel, IN
Peter Kent Hawryluk	Director	Carmel, IN
Peter Kent Hawryluk	Executive Officer	Carmel, IN
Ora Kent Pescovitz	Director	Carmel, IN
Carl M Gordon	Director	Carmel, IN
Richard M Bartram	Executive Officer	Carmel, IN
Timothy Kent Knickerbocker	Director	Carmel, IN
Timothy Kent Knickerbocker	Executive Officer	Carmel, IN

Other filings by this issuer (3)

Filed	Form	Offering	Sold
2022-11-18	D	$115.2M	$46.7M
2020-07-27	D	$35.8M	$25.8M
2019-05-10	D/A	$5.0M	$2.3M

More